#USA #Las Vegas #Wound Care #MolecuLight #SAWC Fall

MolecuLight Showcases Innovative Technologies at SAWC Fall 2025

MolecuLight Inc., a leader in point-of-care fluorescence imaging for wound care, made a significant appearance at the Symposium on Advanced Wound Care (SAWC) Fall 2025 held from September 3-6, in Las Vegas, NV. At this premier multidisciplinary conference, dedicated to advancing wound care, MolecuLight presented ten scientific posters that contribute to the understanding and improvement of patient outcomes.

Groundbreaking Imaging Solutions

The primary focus of MolecuLight's exhibition was the new capabilities of the MolecuLightDX®+ device, an all-in-one hand-held imaging platform designed for accurate bacterial detection, precise wound measurement, and thermal imaging. This year, the device expands to include oxygenation imaging—an innovative feature that allows clinicians to assess oxygen supply in wounds directly.

MolecuLight invited attendees to visit Booth #327, where they could see live demonstrations of the DX®+ device in action. Clinicians and researchers had the opportunity to witness firsthand how the device integrates seamlessly into clinical workflows, enhancing patient assessment and care delivery.

Contributions to Scientific Knowledge

The scientific posters showcased by MolecuLight illuminated various clinical applications of its multimodal imaging platform. The topics presented included:

• - Patient Engagement and Education: Enhancing communication and shared decision-making through imaging.
• - Intraoperative and Preoperative Use: Supporting surgical teams with real-time wound information to improve surgical outcomes.
• - Wound Hygiene and Debridement: Optimizing debridement practices by identifying bacterial hotspots.
• - Thermal Imaging in Wound Care: Exploring the role of temperature mapping for objective wound assessment.

Anil Amlani, the CEO of MolecuLight, expressed pride in contributing to the scientific program, stating, "SAWC Fall is a leading forum for advancements in wound care, and we are excited to showcase the clinical value of our technology. From engaging patients in their care to aiding surgical decision-making and enhancing hygiene practices, our platform is transforming wound assessment."

The upcoming oxygenation imaging features, awaiting FDA submission in Q4 2025, promise to consolidate essential imaging functions into a compact, fully portable system. This functionality not only streamlines clinical documentation but also maximizes time efficiency for healthcare providers.

Integration and Compliance

MolecuLight's devices, including the new DX®+, are designed to integrate seamlessly with leading Electronic Health Records (EHR) systems like Epic, further increasing clinical efficiency and workflow. The company's commitment to data privacy and security is paramount, as its products are HIPAA-compliant and SOC 2 certified. MolecuLight's imaging technology is backed by over 100 peer-reviewed publications, ensuring trust and reliability in clinical settings.

Additionally, the anticipated FDA qualification of the Molecular Measurement Device (MDDT) for the DX® function will further validate the accuracy and reproducibility of MolecuLight's wound measurement technology. This endorsement is vital for positioning the device as a reliable tool for assessing clinical study outcomes and encouraging its use by other wound care manufacturers.

The Future of Wound Care

With more than just imaging technology up for discussion, MolecuLight continues to impact the field of wound care positively. The device's ability to assess bacterial loads, measure wounds accurately, and observe thermal changes with a single unit allows clinicians to turn towards a more integrated and efficient approach to wound management.

MolecuLight looks forward to engaging with attendees and industry leaders during SAWC Fall. The event serves not only as a platform to present technological advancements but also as an opportunity for collaboration and idea exchange among thought leaders in wound care throughout North America.

For more details or inquiries about the innovations presented, guests were encouraged to reach out to Danielle Dunham, Director of Product and Marketing at MolecuLight, or visit their website at moleculight.com.